[1]
“Genomic Biomarkers and Clinical Perspectives of Fluoropyrimidines in Cancer Treatment. A Literature Review”, Genetics and Mol. Res., vol. 24, no. 2, pp. 1–21, Jun. 2025, doi: 10.4238/p6r02x72.